U.S. markets closed

Utah Medical Products, Inc. (UTMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
89.00-0.99 (-1.10%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close89.99
Bid88.30 x 2900
Ask90.87 x 1100
Day's Range86.83 - 91.00
52 Week Range77.80 - 95.65
Avg. Volume10,103
Market Cap324.548M
Beta (5Y Monthly)0.24
PE Ratio (TTM)25.41
EPS (TTM)3.50
Earnings DateOct 25, 2021 - Oct 29, 2021
Forward Dividend & Yield1.14 (1.28%)
Ex-Dividend DateSep 15, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-23% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Utah Medical Products, Inc.
    WST: Lowering target price to $476.00WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $476.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more